About RxBiologics
RxBiologics is part of the RxCelerate group of companies. RxCelerate, was founded in 2013, with a vision to provide a bespoke high quality outsourced drug discovery and development platform. In 2018, RxCelerate made the decision to collaborate with Jonny Finlay, an experienced biotech antibody engineer, and invest in building from first principles a world-leading biologics antibody discovery platform to generate lead antibodies with the desired drug like properties from the beginning.
World-leading biologics antibody discovery
The RxBiologics Galaxy® Antibody Discovery Platform together with RxCelerate biology, in-silico design, chemistry and programme management capabilities, enables us to deliver this vision for biologics drug discovery programmes. We provide comprehensive work packages to support client projects from early discovery through preclinical phases.
Our Galaxy Platform
Galaxy® is our proprietary library technology platform we now offer under RxBiologics.
Our Leadership Team
David Grainger
Co-founder & Executive Chairman
Following an academic career at Cambridge University leading a world-renowned group investigating the biology of chronic inflammation, David joined Index Ventures as a Venture Partner, before co-founding leading European Venture Capital house Medicxi.
Jill Reckless
Co-founder & Director
Co-founder and CEO of RxCelerate. Provides strategic vision to RxCelerate Group. Over 20 years’ experience of translational biology and leading drug discovery programmes covering a wide area of therapeutic indications.
Jonny Finlay
Co-founder & Director
Biotech entrepreneur with two decades of experience in biologics discovery and development in academia, government and pharma.
Nick Tait
CFO
Qualified Chartered Accountant trained at EY. Over 20 years’ experience of providing finance, investor relations and administrative support to companies.
Chris Rossant
VP Scientific Operations
Drug discovery scientist with 20 years plus experience in large pharma, biotechs and CRO’s providing leadership and management of biologics work programmes.
Yun Sanders
Team Manager
Experienced leader of multi-functional teams with extensive biologics and peptide discovery knowledge gained within the biotech sector.
PHIL JONES
VP Discovery
Antibody engineer with over 20 years’ experience and leadership roles in technology development and discovery within biotechs and CROs.